ParaCom An IoT based affordable solution enabling people with limited mobility to interact with machines

There are many people in this world who don’t have the ability to communicate with others due to some unforeseen accident. User’s who are paralyzed and/or suffering from different Motor Neuron Diseases (MND) like Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis etc, by making them more independent. Patients suffering from these diseases are not able to move their arms and legs, lose their body balance and the ability to speak. Here we propose an IoT based communication controller using the concept of Morse Code Technology which controls the smartphone of the user. This paper proposes a solution to give the user ability to communicate to other people using machine as an intermediator. The device will require minimal inputs from the user.

Data in Brief ◽  
2020 ◽  
Vol 29 ◽  
pp. 105229 ◽  
Author(s):  
Peter Bede ◽  
Rangariroyashe H. Chipika ◽  
Eoin Finegan ◽  
Stacey Li Hi Shing ◽  
Kai Ming Chang ◽  
...  

2020 ◽  
Vol 27 ◽  
pp. 102300 ◽  
Author(s):  
Rangariroyashe H. Chipika ◽  
Eoin Finegan ◽  
Stacey Li Hi Shing ◽  
Mary Clare McKenna ◽  
Foteini Christidi ◽  
...  

Author(s):  
Claire Kariya ◽  
Lisa Vardi

Adults with amyotrophic lateral sclerosis (ALS) and primary lateral sclerosis (PLS) may develop swallowing difficulties and elect to receive an enterostomy feeding tube for nutrition support. Blenderized tube feeding (BTF) appeals to those interested in a homemade enteral nutrition option, but there are concerns of feeding tube occlusion and limited research on this potential risk. Therefore, our purpose was to determine the frequency of, and risk factors for, feeding tube occlusions among adults with ALS or PLS who use BTF. For this retrospective study, the electronic medical records of tube-fed adults with ALS or PLS who received outpatient care at a provincial ALS clinic during a two-year period were reviewed (n = 651). There were 97 tube-fed patients identified, of which 20 (21%) used BTF. Average duration of BTF use was 11.25 ± 7.5 months. Seven subjects (35%) used BTF exclusively, while 13 (65%) used a combination of BTF and commercial enteral formula. All received BTF by gastrostomy tube, sized 14 to 24 French. BTF administration methods and compliance with water flush recommendations varied. Despite the perceived risk of feeding tube occlusions with blenderized tube feeding, no occlusions were found to have occurred in this study.


Sign in / Sign up

Export Citation Format

Share Document